SCHOTT Pharma
Marco von Rautenfeld da Fonseca is an experienced professional specializing in continuous improvement and environmental health and safety management. Currently serving as Lean Manager and EHS at SCHOTT Pharma since May 2022, Marco previously held various roles within SCHOTT, including Lean Manager, as well as working as a freelance consultant and Continuous Improvement Expert at MANN+HUMMEL Group. With a solid foundation in Lean methodologies, Marco has been responsible for deploying management systems, training staff, and implementing tools such as 5S and VSM. Marco's educational background includes a degree in Mechanical Engineering from FEI, an MBA in Industrial Management from FGV, a specialization in Environmental Management from Universidade Estadual de Campinas, and ongoing study for a Green Belt in Lean Six Sigma from Fundação Vanzolini.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social